Quality-of-life assessment in a randomized, double-blind study of sipuleucel-T in men with androgen-dependent prostate cancer.

Tomasz M. Beer,Paul F. Schellhammer,John M. Corman,L. M. Glode,Simon J. Hall,Y. Xu,Mark W. Frohlich,David F. Penson

Quality-of-life assessment in a randomized, double-blind study of sipuleucel-T in men with androgen-dependent prostate cancer.

2011

Tomasz M. Beer
Paul F. Schellhammer
John M. Corman
L. M. Glode
Simon J. Hall
Y. Xu
Mark W. Frohlich
David F. Penson

4648 Background: Sipuleucel-T is an autologous cellular immunotherapy designed to stimulate an immune response to prostate cancer. P-11 is a phase III study in men with prostate specific antigen (P...

Keywords:

Sipuleucel-T
Androgen
Urology
Physical therapy
Prostate cancer
Oncology
Medicine
Internal medicine
double blind study
Autologous Cellular Immunotherapy
Prostate-specific antigen
Immune system
androgen dependent
Quality of life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations